HCA Healthcare Inc (NYSE:HCA) Expected to Post Earnings of $3.06 Per Share

Share on StockTwits

Brokerages predict that HCA Healthcare Inc (NYSE:HCA) will report $3.06 earnings per share for the current fiscal quarter, according to Zacks. Nine analysts have made estimates for HCA Healthcare’s earnings. The highest EPS estimate is $3.19 and the lowest is $2.96. HCA Healthcare reported earnings per share of $2.99 during the same quarter last year, which would indicate a positive year over year growth rate of 2.3%. The firm is scheduled to issue its next quarterly earnings report on Tuesday, February 4th.

On average, analysts expect that HCA Healthcare will report full year earnings of $10.51 per share for the current year, with EPS estimates ranging from $10.41 to $10.60. For the next fiscal year, analysts anticipate that the company will post earnings of $11.63 per share, with EPS estimates ranging from $11.39 to $11.85. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that cover HCA Healthcare.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.23 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.13 by $0.10. The company had revenue of $12.69 billion for the quarter, compared to the consensus estimate of $12.48 billion. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The firm’s revenue was up 10.9% compared to the same quarter last year. During the same period last year, the company earned $2.16 earnings per share.

Several research firms recently issued reports on HCA. ValuEngine upgraded HCA Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Stephens set a $150.00 price target on HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, August 7th. Bank of America raised HCA Healthcare from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $130.00 to $137.00 in a research report on Friday, September 6th. Finally, Barclays upped their price objective on HCA Healthcare from $145.00 to $155.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $155.69.

Shares of NYSE HCA traded up $2.71 during mid-day trading on Wednesday, hitting $140.88. The company had a trading volume of 684,330 shares, compared to its average volume of 1,377,894. The firm has a 50-day simple moving average of $133.23 and a two-hundred day simple moving average of $129.08. The company has a market capitalization of $47.03 billion, a PE ratio of 14.42, a price-to-earnings-growth ratio of 1.17 and a beta of 0.91. HCA Healthcare has a one year low of $110.31 and a one year high of $147.42.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 2nd will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Friday, November 29th. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.

In related news, insider Jon M. Foster sold 19,477 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $132.35, for a total transaction of $2,577,780.95. Following the transaction, the insider now directly owns 10,015 shares of the company’s stock, valued at approximately $1,325,485.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Christopher F. Wyatt sold 3,900 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $134.74, for a total value of $525,486.00. Following the transaction, the senior vice president now directly owns 27,353 shares in the company, valued at $3,685,543.22. The disclosure for this sale can be found here. Insiders sold 40,571 shares of company stock worth $5,431,851 in the last 90 days. Corporate insiders own 2.70% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the business. NEXT Financial Group Inc bought a new position in shares of HCA Healthcare in the second quarter valued at about $43,000. Commonwealth Equity Services LLC grew its stake in HCA Healthcare by 2.4% in the 2nd quarter. Commonwealth Equity Services LLC now owns 8,872 shares of the company’s stock valued at $1,199,000 after buying an additional 209 shares during the last quarter. Westside Investment Management Inc. bought a new position in HCA Healthcare in the 2nd quarter valued at about $34,000. Arizona State Retirement System raised its holdings in HCA Healthcare by 2.4% in the 2nd quarter. Arizona State Retirement System now owns 69,594 shares of the company’s stock valued at $9,407,000 after acquiring an additional 1,648 shares during the period. Finally, Hartford Investment Management Co. raised its holdings in HCA Healthcare by 1.0% in the 2nd quarter. Hartford Investment Management Co. now owns 29,292 shares of the company’s stock valued at $3,959,000 after acquiring an additional 290 shares during the period. 69.40% of the stock is owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Closed-End Mutual Funds (CEFs)

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.